1. Home
  2. FLGT vs EOI Comparison

FLGT vs EOI Comparison

Compare FLGT & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$26.96

Market Cap

697.3M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest

EOI

Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest

HOLD

Current Price

$19.83

Market Cap

805.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLGT
EOI
Founded
2011
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
697.3M
805.7M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
FLGT
EOI
Price
$26.96
$19.83
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$28.33
N/A
AVG Volume (30 Days)
272.3K
83.6K
Earning Date
11-07-2025
01-01-0001
Dividend Yield
N/A
7.19%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$315,549,000.00
N/A
Revenue This Year
$16.84
N/A
Revenue Next Year
$9.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.61
N/A
52 Week Low
$14.57
$14.36
52 Week High
$31.04
$18.88

Technical Indicators

Market Signals
Indicator
FLGT
EOI
Relative Strength Index (RSI) 45.89 48.58
Support Level $26.69 $19.47
Resistance Level $31.04 $19.79
Average True Range (ATR) 0.74 0.23
MACD -0.44 0.05
Stochastic Oscillator 9.29 71.05

Price Performance

Historical Comparison
FLGT
EOI

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About EOI Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest

Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation. The company's sector allocation includes: Information Technology, Communication Services, Financials, Consumer Discretionary, Healthcare, Industries, Consumer Staples, Energy, Real Estate, and Materials.

Share on Social Networks: